Acurx Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-14.58	-12.09	-12.75	-4.6	-5.93
Share-Based Compensation	3.21	2.87	6.07	1.48	0.57
Other Operating Activities	1.57	1.68	1.66	-0.23	1.38
Operating Cash Flow	-9.8	-7.54	-5.01	-3.35	-3.99
Share Issuance / Repurchase	5.94	3.7	14.8	3.98	4.46
Debt Issued / Paid	0	0	0	0.07	0
Other Financing Activities	2.22	0	-	-	-
Financing Cash Flow	8.16	3.7	14.8	4.04	4.46
Net Cash Flow	-1.64	-3.85	9.78	0.69	0.47
Free Cash Flow	-9.8	-7.54	-5.01	-3.35	-3.99
Free Cash Flow Per Share	-0.77	-0.70	-0.59	-0.54	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).